New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Palisade Bio, Inc.
PALI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4M

Biotechnology

Next Earning date - 14 Nov 2024

4M

Biotechnology

Next Earning date - 14 Nov 2024

3.60USD
Shape0.10 ( 2.86%)
Market Open
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-72%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated October 25, 2024
1W -7.93 % 1M 6.82 % 3M -15.49 % 1Y -58.72 %

Key Metrics

Shape
  • Market Cap

    4.26M


  • Shares Outstanding

    1.18M


  • Share in Float

    1.16M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    3.6


  • Average Volume

    56782


  • Beta

    1.314


  • Range

    3.14-22.35


  • Industry

    Biotechnology


  • Website

    https://www.palisadebio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

0.43x

P/B Ratio

0.1

Debt/Equity

5669.6%

Net Margin

$-18.6

EPS

How PALI compares to sector?

P/E Ratio

Relative Strength

Shape

PALI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$12M

ShapeNaN%

2025-Revenue

$9.12

Shape-175%

2025-EPS

$2M

Shape42%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Maxim Group

upgrade

Previous: Not converted

2023-03-30

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-59.97
vs -224.89

Q4.22

arrow
arrow

-99%

6.47
vs 554.72

Q1.23

arrow
arrow

N/A

-8.10
vs -194.90

Q2.23

arrow
arrow

N/A

-7.95
vs -89.96

Q3.23

arrow
arrow

N/A

-7.35
vs -59.97

Q4.23

arrow
arrow

N/A

-3.75
vs 6.47

Q1.24

arrow
arrow

N/A

-4.59
vs -8.10

Q2.24

arrow
arrow

N/A

-3.32
vs -7.95

Q3.24

arrow
arrow

N/A

-3.35
vs -7.35

Q4.24

arrow
arrow

N/A

-2.33
vs -3.75

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

250K  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

-250000.00  vs NA

Q1.24

arrow
arrow

-100%

NA  vs 250K

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-32%

-0.32
vs -0.27

Q4.22

arrow
arrow

-21%

-0.21
vs -0.32

Q1.23

arrow
arrow

-16%

-0.16
vs -0.21

Q2.23

arrow
arrow

-21%

-0.21
vs -0.16

Q3.23

arrow
arrow

-26%

-0.26
vs -0.21

Q4.23

arrow
arrow

-26%

-0.26
vs -0.26

Q1.24

arrow
arrow

-35%

-0.35
vs -0.26

Q2.24

arrow
arrow

-41%

-0.41
vs -0.35

Institutionnal OwnershipShape

status-upQoQ

Q2.21

arrow
arrow

17

17
vs NA

NA

Q3.21

arrow
arrow

15

15
vs 17

-12%

Q4.21

arrow
arrow

21

21
vs 15

40%

Q1.22

arrow
arrow

19

19
vs 21

-10%

Q2.22

arrow
arrow

16

16
vs 19

-16%

Q3.22

arrow
arrow

24

24
vs 16

50%

Earnings Growth

Latest News